外科用スポンジ市場 – 2029年までの世界予測

Surgical Sponges Market - Global Forecast to 2029

外科用スポンジ市場 - タイプ(開腹用スポンジ、綿ガーゼ)、材質(綿、レーヨン、PVA)、形状(正方形、長方形)、無菌性(滅菌、非滅菌)、用途(脳神経外科、開腹術、耳鼻咽喉科、一般外科) - 2029年までの世界予測
Surgical Sponges Market by Type (Laparotomy Sponges, Cotton Gauze), Material (Cotton, Rayon, PVA), Shape (Square, Rectangle), Sterility (Sterile, Non-sterile), Application (Neurosurgery, Laparotomy, ENT, General Surgery) - Global Forecast to 2029
出版社MarketsandMarkets
出版年月2024年8月
ページ数284
図表数372
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Report Overview

The global surgical sponges market is valued at an estimated 0.81 billion in 2024 and is projected to reach USD 1.19 billion by 2029, at a CAGR of 7.9% during the forecast period.

世界の外科用スポンジ市場は2024年に8億1,000万米ドルと推定され、予測期間中のCAGRは7.9%で、2029年までに11億9,000万米ドルに達すると予測されています。

外科用スポンジ市場 - 2029年までの世界予測

The rise in trauma cases and accidents, as well as the development of the healthcare infrastructure, are the primary drivers of the surgical sponges market’s growth. Sterile surgical sponges and other useful surgical supplies are becoming more and more necessary as the frequency of procedures linked to trauma and accidents rises. Therefore, if trauma and accidents become more widespread, there will likely be a greater need for surgical sponges.

“The x-ray detectable sponges segment is projected to witness highest growth rate in the surgical sponges market, by type, during the forecast period”

Based on type, the surgical sponges market is segmented into x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges. The ability of x-ray detectable sponges to significantly enhance patient safety by reducing the risk of retained surgical items by identifying leftover surgical items such as surgical sponges during surgical procedures, contributes to their extensive usage and market demand during the forecast period.

外科用スポンジ市場 - 2029年までの世界予測 ecosystem

“The cotton segment is projected to witness the highest growth rate in the surgical sponges market, by material, during the forecast period.”

Based on material, the surgical sponges market is segmented into cotton, rayon, PVA, and other materials. Cotton is cost-effective, it also have high absorbency, and it is easily available material in most of the regions. Which is making cotton a best choice for hospitals and ambulatory surgical centers, especially in high-volume settings. These factors are contributing to growth of this segment.

“The square & rectangle segment is projected to witness the highest growth rate in the surgical sponges market, in 2023, by shape”

Based on shape, the surgical sponges market is segmented into round & cylindrical, square & rectangle, and other shapes. The square and rectangular shapes make surgical sponges suitable for a range of surgical applications where effective blood and other fluid absorption and coverage are required. Which is contributing to their extensive adoption and market demand during the forecast period.

“The hospitals & ambulatory surgery centers segment is projected to witness the highest growth rate in the surgical sponges market in 2023, by end user”.

Based on end users, the surgical sponges market is segmented hospitals & ambulatory surgery centers, and specialty clinics. The expansion of healthcare infrastructure, particularly in emerging markets, has led to an increase in number of hospitals and ASCs, driving demand for surgical sponges among these end users during the forecasted period.

“The Asia Pacific region is projected to witness highest growth rate in the surgical sponges market during the forecast period”

The global surgical sponges market is segmented into six regions – North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and the GCC Countries. Over the span of the forecast period, the surgical sponges market is expected to grow at the fastest rate in the Asia Pacific region. Over the projected period, the Asia Pacific market is expected to develop at the greatest rate due to factors such government initiatives to raise awareness about illness management and the growing number of hospitals and clinics in China and India.

外科用スポンジ市場 - 2029年までの世界予測 region

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
  • By Designation: C-level – 27%, D-level – 18%, and Others – 55%
  • By Region: North America – 35%, Europe – 24%, Asia Pacific – 26%, Latin America – 12%, Middle East & Africa – 2%, and the GCC Countries – 1%

Lists of Companies Profiled in the Report:

Johnson & Johnson Services, Inc. (US), Medline Industries, LP (US), Cardinal Health (US), Integra LifeSciences Corporation (US), Dynarex corporation (US), 3M (US), Medicom (Canada), McKesson Corporation (US), Dukal, LLC (US), DeRoyal Industries, Inc. (US), Owens & Minor Inc. (US), AdvaCare Pharma (US), First aid bandage company (US), AllCare (US), Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Aegis Lifesciences (India), SUNDARAM SURGICAL (India), Omni International Corp (US), and Aspen Surgical Products, Inc.(US).

Research Coverage:

In this report, the surgical sponges market has been categorized based on material (cotton, rayon, PVA, and other materials), end user (hospitals & ambulatory surgery centers, and specialty clinics), sterility (sterile surgical sponge, and non-sterile surgical sponge), type (x-ray detectable sponges, cotton gauze sponges, laparotomy sponges, nonwoven sponges, and other surgical sponges), application (general surgery, neurosurgery, laparotomy, dental surgery, ENT surgery, and other applications), shape (round & cylindrical, square & rectangle, and other shapes), and region (North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and the GCC Countries).

Comprehensive information regarding the main drivers, barriers, opportunities, and trends influencing the surgical sponges market’s expansion is included in detail in this study. An exhaustive study of the key players in the surgical sponges market has been done to provide insights into their business profile, products offered, noteworthy strategies, acquisitions and expansions, and other recent activities pertaining to the market. This study examines the competitive landscape of emerging surgical sponge startups.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall surgical sponges market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, trends, opportunities, and restaints.

The report provides insights on the following pointers:

Analysis of key drivers: (Rising number of surgical procedures performed, increasing cases of trauma and accidents, growing gearitric population and increasing prevalence of chronic diseases, and growing healthcare infrastructure), restraints (Risk of retained surgical items (RSIs)), opportunities (Increased adoption of outpatient surgeries, and growth opportunities in emerging economies), and trends (Technological advancements in surgical sponges, and developmentand adoption of biodegradable surgical sponges) influencing the growth of the in surgical sponges market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the surgical sponges market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the surgical sponges market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like Johnson & Johnson Services, Inc. (US), Cardinal Health (US), and McKesson Corporation (US) are among others, in the surgical sponges market strategies.

Table of Contents

1            INTRODUCTION            26

1.1         STUDY OBJECTIVES      26

1.2         MARKET DEFINITION   26

1.3         STUDY SCOPE  27

1.3.1      MARKETS COVERED     27

1.3.2      INCLUSIONS & EXCLUSIONS     28

1.3.3      YEARS CONSIDERED     28

1.3.4      CURRENCY CONSIDERED          29

1.4         STAKEHOLDERS            29

2            RESEARCH METHODOLOGY     30

2.1         RESEARCH DATA           30

2.1.1      SECONDARY DATA       31

2.1.1.1   Key data from secondary sources     32

2.1.2      PRIMARY DATA 32

2.1.2.1   Primary sources   32

2.1.2.2   Key data from primary sources         33

2.1.2.3   Key industry insights          34

2.1.2.4   Breakdown of primary interviews     35

2.2         MARKET SIZE ESTIMATION       35

2.2.1      BOTTOM-UP APPROACH           36

2.2.1.1   Approach 1: Company revenue estimation approach    36

2.2.2      TOP-DOWN APPROACH             38

2.3         MARKET BREAKDOWN AND DATA TRIANGULATION    39

2.4         MARKET SHARE ANALYSIS         41

2.5         STUDY ASSUMPTIONS  41

2.5.1      GROWTH RATE ASSUMPTIONS 41

2.6         RESEARCH LIMITATIONS           42

2.6.1      METHODOLOGY-RELATED LIMITATIONS         42

2.6.2      SCOPE-RELATED LIMITATIONS             42

2.7         RISK ASSESSMENT         42

3            EXECUTIVE SUMMARY 43

4            PREMIUM INSIGHTS      48

4.1         SURGICAL SPONGES MARKET OVERVIEW          48

4.2         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE AND COUNTRY (2023)   49

4.3         SURGICAL SPONGES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           50

4.4         SURGICAL SPONGES MARKET: REGIONAL MIX (2024–2029)         51

4.5         SURGICAL SPONGES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES     51

5            MARKET OVERVIEW     52

5.1         INTRODUCTION            52

5.2         MARKET DYNAMICS     52

5.2.1      DRIVERS            53

5.2.1.1   Rising number of surgical procedures performed         53

5.2.1.2   Increasing trauma and accident cases             54

5.2.1.3   Growing geriatric population and increasing prevalence of chronic diseases              54

5.2.1.4   Healthcare infrastructural development and expansion 55

5.2.2      RESTRAINTS     56

5.2.2.1   Risk of retained surgical items          56

5.2.3      OPPORTUNITIES           57

5.2.3.1   Growth opportunities in emerging economies 57

5.2.3.2   Increased adoption of outpatient surgeries     58

5.2.4      TRENDS             58

5.2.4.1   Development and adoption of biodegradable surgical sponges   58

5.2.4.2   Technological advancements in surgical sponges          58

5.3         PRICING ANALYSIS        59

5.3.1      AVERAGE SELLING PRICE TREND, BY PRODUCT            59

5.3.2      AVERAGE SELLING PRICE TREND, BY REGION  60

5.4         VALUE CHAIN ANALYSIS            60

5.5         SUPPLY CHAIN ANALYSIS          61

5.6         ECOSYSTEM ANALYSIS 62

5.6.1      SURGICAL SPONGES MARKET: ROLE IN ECOSYSTEM     63

5.7         PORTER’S FIVE FORCES ANALYSIS         64

5.7.1      THREAT OF NEW ENTRANTS    65

5.7.2      THREAT OF SUBSTITUTES         65

5.7.3      BARGAINING POWER OF SUPPLIERS     66

5.7.4      BARGAINING POWER OF BUYERS           66

5.7.5      INTENSITY OF COMPETITIVE RIVALRY 66

5.8         KEY STAKEHOLDERS AND BUYING CRITERIA    67

5.8.1      KEY STAKEHOLDERS IN BUYING PROCESS         67

5.8.2      BUYING CRITERIA         67

5.9         REGULATORY LANDSCAPE       68

5.9.1      NORTH AMERICA          68

5.9.1.1   US         68

5.9.1.2   Canada  69

5.9.2      EUROPE             69

5.9.3      ASIA PACIFIC    69

5.9.3.1   Japan     69

5.9.3.2   China     70

5.9.3.3   India      71

5.9.4      LATIN AMERICA             71

5.9.4.1   Brazil     71

5.9.4.2   Mexico  71

5.9.5      MIDDLE EAST  72

5.9.6      AFRICA 72

5.9.7      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          72

5.10       TRADE ANALYSIS          74

5.10.1    IMPORT DATA FOR SURGICAL SPONGES           74

5.10.2    EXPORT DATA FOR SURGICAL SPONGES           74

5.11       PATENT ANALYSIS        75

5.11.1    LIST OF MAJOR PATENTS          76

5.12       KEY CONFERENCES AND EVENTS, 2024–2025     76

5.13       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77

5.14       INVESTMENT & FUNDING SCENARIO    78

5.15       IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON SURGICAL SPONGES MARKET            78

6            SURGICAL SPONGES MARKET, BY TYPE 79

6.1         INTRODUCTION            80

6.2         COTTON GAUZE SPONGES       80

6.2.1      SUPERIOR PROPERTIES OF COTTON GAUZE TO PROPEL GROWTH              80

6.3         X-RAY-DETECTABLE SPONGES 83

6.3.1      ENHANCED PATIENT SAFETY TO BOOST DEMAND       83

6.4         NONWOVEN SPONGES 86

6.4.1      LINT-FREE NATURE OF NONWOVEN SPONGES TO DRIVE GROWTH              86

6.5         LAPAROTOMY SPONGES           89

6.5.1      RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET              89

6.6         OTHER SURGICAL SPONGES     92

7            SURGICAL SPONGES MARKET, BY MATERIAL    95

7.1         INTRODUCTION            96

7.2         COTTON           96

7.2.1      HIGH ABSORBENCY AND WIDE AVAILABILITY TO BOOST MARKET              96

7.3         RAYON 99

7.3.1      EXCEPTIONAL ABSORBENCY AND SOFTNESS TO PROPEL GROWTH              99

7.4         PVA      101

7.4.1      BIOCOMPATIBILITY OF PVA SPONGES TO DRIVE ADOPTION   101

7.5         OTHER MATERIALS      104

8            SURGICAL SPONGES MARKET, BY SHAPE           107

8.1         INTRODUCTION            108

8.2         SQUARE & RECTANGLE 108

8.2.1      ADAPTABILITY AND WIDE USE TO BOOST MARKET GROWTH  108

8.3         ROUND & CYLINDRICAL            111

8.3.1      PRECISION AND EASE OF MAINTAINING PATIENT SAFETY TO DRIVE MARKET            111

8.4         OTHER SHAPES 114

9            SURGICAL SPONGES MARKET, BY STERILITY    118

9.1         INTRODUCTION            119

9.2         STERILE SURGICAL SPONGES   119

9.2.1      EMPHASIS ON INFECTION CONTROL AND PREVENTION IN HEALTHCARE SETTINGS TO PROMOTE MARKET GROWTH       119

9.3         NON-STERILE SURGICAL SPONGES       122

9.3.1      WIDE USE IN CLEANING WOUNDS AND DRESSING MINOR INJURIES TO PROPEL GROWTH         122

10          SURGICAL SPONGES MARKET, BY APPLICATION            126

10.1       INTRODUCTION            127

10.2       GENERAL SURGERY      127

10.2.1    RISING NUMBER OF HERNIA REPAIR PROCEDURES TO DRIVE MARKET              127

10.3       NEUROSURGERY           130

10.3.1    GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH        130

10.4       LAPAROTOMY 133

10.4.1    RISING NUMBER OF LAPAROTOMY PROCEDURES WORLDWIDE TO DRIVE MARKET 133

10.5       DENTAL SURGERY        136

10.5.1    RISING PREVALENCE OF ORAL DISEASES AND GROWING AWARENESS OF DENTAL CARE TO DRIVE GROWTH 136

10.6       ENT SURGERY  139

10.6.1    INCREASING DISPOSABLE INCOME AND AFFORDABILITY TO BOOST GROWTH          139

10.7       OTHER APPLICATIONS 142

11          SURGICAL SPONGES MARKET, BY END USER     146

11.1       INTRODUCTION            147

11.2       HOSPITALS & AMBULATORY SURGERY CENTERS           147

11.2.1    RISING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS IN HEALTHCARE TO PROMOTE MARKET GROWTH            147

11.3       SPECIALTY CLINICS      150

11.3.1    GROWING NUMBER OF SURGERIES TO DRIVE MARKET 150

12          SURGICAL SPONGES MARKET, BY REGION         154

12.1       INTRODUCTION            155

12.2       NORTH AMERICA          155

12.2.1    MACROECONOMIC OUTLOOK FOR NORTH AMERICA   156

12.2.2    US         160

12.2.2.1 Strong healthcare infrastructure to support market growth         160

12.2.3    CANADA            163

12.2.3.1 Growing geriatric population and increasing volume of surgeries to drive demand              163

12.3       EUROPE             166

12.3.1    MACROECONOMIC OUTLOOK FOR EUROPEAN UNION 167

12.3.2    GERMANY         170

12.3.2.1 Increasing healthcare expenditure and rising per capita disposable income to propel market      170

12.3.3    UK         173

12.3.3.1 Growing volume of cardiovascular surgeries to drive market      173

12.3.4    FRANCE             176

12.3.4.1 Presence of robust healthcare systems to augment market         176

12.3.5    ITALY   179

12.3.5.1 Rising geriatric population and increasing number of chronic diseases to support market   179

12.3.6    SPAIN   182

12.3.6.1 Growing demand for effective surgical outcomes to create major growth opportunities       182

12.3.7    REST OF EUROPE           185

12.4       ASIA PACIFIC    189

12.4.1    MACROECONOMIC OUTLOOK FOR EAST ASIA & PACIFIC           189

12.4.2    CHINA  193

12.4.2.1 Rising number of hospitals and greater public access to modern healthcare to drive market   193

12.4.3    JAPAN  197

12.4.3.1 Rising prevalence of chronic diseases and robust healthcare system to support market   197

12.4.4    INDIA   200

12.4.4.1 Large patient population and developing healthcare sector to drive market              200

12.4.5    REST OF ASIA PACIFIC  203

12.5       LATIN AMERICA             205

12.5.1    MACROECONOMIC OUTLOOK FOR LATIN AMERICA & CARIBBEAN              206

12.5.2    BRAZIL 209

12.5.2.1 Increasing cases of accidents and traumas to fuel market            209

12.5.3    MEXICO             212

12.5.3.1 Low-cost surgeries and enhanced healthcare infrastructure to aid market 212

12.5.4    REST OF LATIN AMERICA          215

12.6       MIDDLE EAST & AFRICA             218

12.6.1    INCREASED HEALTHCARE INVESTMENTS TO PROPEL MARKET              218

12.6.2    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & NORTH AFRICA              219

12.7       GCC COUNTRIES           222

12.7.1    ADVANCEMENTS AND INCREASED GOVERNMENT INVESTMENTS IN HEALTHCARE SECTOR TO PROPEL MARKET     222

12.7.2    MACROECONOMIC OUTLOOK FOR GCC COUNTRIES    223

13          COMPETITIVE LANDSCAPE       227

13.1       OVERVIEW        227

13.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          227

13.2.1    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN SURGICAL SPONGES MARKET        227

13.3       REVENUE ANALYSIS      228

13.4       MARKET SHARE ANALYSIS         229

13.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   231

13.5.1    STARS  231

13.5.2    EMERGING LEADERS    231

13.5.3    PERVASIVE PLAYERS     231

13.5.4    PARTICIPANTS 231

13.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      233

13.5.5.1 Company footprint            233

13.5.5.2 Type footprint     234

13.5.5.3 Material footprint 234

13.5.5.4 Shape footprint    235

13.5.5.5 Sterility footprint 235

13.5.5.6 Application footprint         236

13.5.5.7 End-user footprint             236

13.5.5.8 Region footprint  237

13.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          237

13.6.1    PROGRESSIVE COMPANIES       237

13.6.2    STARTING BLOCKS       237

13.6.3    RESPONSIVE COMPANIES          238

13.6.4    DYNAMIC COMPANIES 238

13.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             239

13.7       VALUATION & FINANCIAL METRICS      240

13.8       BRAND/PRODUCT COMPARISON          241

13.9       COMPETITIVE SCENARIO          242

13.9.1    DEALS  242

13.9.2    EXPANSIONS    242

13.9.3    OTHER DEVELOPMENTS           242

14          COMPANY PROFILES    243

14.1       KEY PLAYERS   243

14.1.1    JOHNSON & JOHNSON SERVICES, INC.  243

14.1.1.1 Business overview 243

14.1.1.2 Products offered  244

14.1.1.3 MnM view           245

14.1.1.3.1            Right to win         245

14.1.1.3.2            Strategic choices  245

14.1.1.3.3            Weaknesses & competitive threats   245

14.1.2    MCKESSON CORPORATION       246

14.1.2.1 Business overview 246

14.1.2.2 Products offered  247

14.1.2.3 MnM view           247

14.1.2.3.1            Key strengths       247

14.1.2.3.2            Strategic choices  248

14.1.2.3.3            Weaknesses and competitive threats 248

14.1.3    CARDINAL HEALTH      249

14.1.3.1 Business overview 249

14.1.3.2 Products offered  250

14.1.3.3 MnM view           251

14.1.3.3.1            Key strengths       251

14.1.3.3.2            Strategic choices  251

14.1.3.3.3            Weaknesses and competitive threats 251

14.1.4    3M         252

14.1.4.1 Business overview 252

14.1.4.2 Products offered  253

14.1.4.3 Recent developments         254

14.1.4.3.1            Other developments          254

14.1.4.4 MnM view           254

14.1.4.4.1            Key strengths       254

14.1.4.4.2            Strategic choices  254

14.1.4.4.3            Weaknesses and competitive threats 254

14.1.5    INTEGRA LIFESCIENCES CORPORATION            255

14.1.5.1 Business overview 255

14.1.5.2 Products offered  256

14.1.5.3 Recent developments         257

14.1.5.3.1            Deals     257

14.1.6    MEDICOM         258

14.1.6.1 Business overview 258

14.1.6.2 Products offered  258

14.1.7    MEDLINE INDUSTRIES, LP.        260

14.1.7.1 Business overview 260

14.1.7.2 Product offered   260

14.1.7.3 Recent developments         261

14.1.7.3.1            Expansions          261

14.1.8    DEROYAL INDUSTRIES, INC.      262

14.1.8.1 Business overview 262

14.1.8.2 Product offered   262

14.1.9    DUKAL LLC       263

14.1.9.1 Business overview 263

14.1.9.2 Product offered   263

14.1.10  DYNAREX CORPORATION         265

14.1.10.1             Business overview 265

14.1.10.2             Product offered   265

14.2       OTHER PLAYERS           266

14.2.1    OWENS & MINOR           266

14.2.2    ADVACARE PHARMA    267

14.2.3    FIRST AID BANDAGE COMPANY             268

14.2.4    MÖLNLYCKE HEALTH CARE AB 269

14.2.5    ALLCARE           270

14.2.6    NARANG MEDICAL LIMITED     271

14.2.7    AEGIS LIFESCIENCES    272

14.2.8    SUNDARAM SURGICAL 273

14.2.9    ASPEN SURGICAL PRODUCTS   274

14.2.10  OMNI INTERNATIONAL CORP  274

15          APPENDIX         275

15.1       DISCUSSION GUIDE      275

15.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             280

15.3       CUSTOMIZATION OPTIONS      282

15.4       RELATED REPORTS       282

15.5       AUTHOR DETAILS         283

LIST OF TABLES

TABLE 1             NUMBER OF SURGERIES PERFORMED, BY COUNTRY AND TYPE, 2021 VS. 2022        53

TABLE 2             INDIA: TOTAL NUMBER OF ACCIDENTS, FATALITIES, AND INJURIES, 2018 TO 2022 54

TABLE 3             TOTAL NUMBER OF CORONARY ARTERY BYPASS GRAFT PROCEDURES,

2021 VS. 2022     55

TABLE 4             COST OF SURGICAL PROCEDURES: US VS. INDIA (USD) 57

TABLE 5             AVERAGE SELLING PRICE TREND OF KEY SURGICAL SPONGE PRODUCTS,

2021–2023          59

TABLE 6             AVERAGE SELLING PRICE TREND OF SURGICAL SPONGES, BY REGION,

2021–2023          60

TABLE 7             SURGICAL SPONGES MARKET: PORTER’S FIVE FORCES ANALYSIS          64

TABLE 8             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67

TABLE 9             KEY BUYING CRITERIA FOR SURGICAL SPONGE END USERS              68

TABLE 10           CLASSIFICATION OF MEDICAL DEVICES BY US FDA       69

TABLE 11           CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 70

TABLE 12           NMPA MEDICAL DEVICES CLASSIFICATION       70

TABLE 13           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 72

TABLE 14           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 73

TABLE 15           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 73

TABLE 16           REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 73

TABLE 17           IMPORT DATA FOR SURGICAL SPONGES (HS CODE 901890), BY COUNTRY,

2018–2023 (USD MILLION)          74

TABLE 18           EXPORT DATA FOR SURGICAL SPONGES (HS CODE 901890), BY COUNTRY,

2018–2023 (USD MILLION)          74

TABLE 19           SURGICAL SPONGES MARKET: DETAILED LIST OF CONFERENCES

AND EVENTS, 2024–2025             76

TABLE 20           SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          80

TABLE 21           COTTON GAUZE SPONGES: PRODUCTS OFFERED, BY COMPANY         81

TABLE 22           COTTON GAUZE SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 81

TABLE 23           NORTH AMERICA: COTTON GAUZE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          81

TABLE 24           EUROPE: COTTON GAUZE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          82

TABLE 25           ASIA PACIFIC: COTTON GAUZE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          82

TABLE 26           LATIN AMERICA: COTTON GAUZE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          83

TABLE 27           X-RAY-DETECTABLE SPONGES: PRODUCTS OFFERED, BY COMPANY         83

TABLE 28           X-RAY-DETECTABLE SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION)     84

TABLE 29           NORTH AMERICA: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          84

TABLE 30           EUROPE: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          85

TABLE 31           ASIA PACIFIC: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          85

TABLE 32           LATIN AMERICA: X-RAY-DETECTABLE SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          86

TABLE 33           NONWOVEN SPONGES: PRODUCTS OFFERED, BY COMPANY              86

TABLE 34           NONWOVEN SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION)          87

TABLE 35           NORTH AMERICA: NONWOVEN SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          87

TABLE 36           EUROPE: NONWOVEN SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          88

TABLE 37           ASIA PACIFIC: NONWOVEN SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          88

TABLE 38           LATIN AMERICA: NONWOVEN SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          89

TABLE 39           LAPAROTOMY SPONGES: PRODUCTS OFFERED, BY COMPANY              89

TABLE 40           LAPAROTOMY SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION)          90

TABLE 41           NORTH AMERICA: LAPAROTOMY SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          90

TABLE 42           EUROPE: LAPAROTOMY SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          91

TABLE 43          ASIA PACIFIC: LAPAROTOMY SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)        91

TABLE 44           LATIN AMERICA: LAPAROTOMY SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          92

TABLE 45           OTHER SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 92

TABLE 46           NORTH AMERICA: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          93

TABLE 47           EUROPE: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          93

TABLE 48           ASIA PACIFIC: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          94

TABLE 49           LATIN AMERICA: OTHER SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          94

TABLE 50           SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)          96

TABLE 51           COTTON SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 97

TABLE 52           NORTH AMERICA: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          97

TABLE 53           EUROPE: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          98

TABLE 54           ASIA PACIFIC: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          98

TABLE 55           LATIN AMERICA: COTTON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          99

TABLE 56           RAYON SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 99

TABLE 57           NORTH AMERICA: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          100

TABLE 58           EUROPE: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          100

TABLE 59           ASIA PACIFIC: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          101

TABLE 60           LATIN AMERICA: RAYON SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          101

TABLE 61           PVA SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION)          102

TABLE 62           NORTH AMERICA: PVA SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          102

TABLE 63           EUROPE: PVA SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          103

TABLE 64           ASIA PACIFIC: PVA SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          103

TABLE 65           LATIN AMERICA: PVA SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          104

TABLE 66           OTHER SURGICAL SPONGE MATERIALS MARKET, BY REGION,

2022–2029 (USD MILLION)        104

TABLE 67           NORTH AMERICA: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         105

TABLE 68           EUROPE: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          105

TABLE 69           ASIA PACIFIC: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         106

TABLE 70           LATIN AMERICA: OTHER SURGICAL SPONGE MATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         106

TABLE 71           SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION)          108

TABLE 72           SQUARE & RECTANGLE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY            109

TABLE 73           SQUARE & RECTANGULAR SURGICAL SPONGES MARKET, BY REGION,

2022–2029 (USD MILLION)          109

TABLE 74           NORTH AMERICA: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            110

TABLE 75           EUROPE: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         110

TABLE 76           ASIA PACIFIC: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            111

TABLE 77           LATIN AMERICA: SQUARE & RECTANGULAR SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            111

TABLE 78           ROUND & CYLINDRICAL SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY            112

TABLE 79           ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY REGION,

2022–2029 (USD MILLION)          112

TABLE 80           NORTH AMERICA: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            112

TABLE 81           EUROPE: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         113

TABLE 82           ASIA PACIFIC: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         113

TABLE 83           LATIN AMERICA: ROUND & CYLINDRICAL SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            114

TABLE 84          SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY REGION,

2022–2029 (USD MILLION)          115

TABLE 85           NORTH AMERICA: SURGICAL SPONGES MARKET FOR OTHER SHAPES,

BY COUNTRY, 2022–2029 (USD MILLION)            115

TABLE 86           EUROPE: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY,

2022–2029 (USD MILLION)          116

TABLE 87           ASIA PACIFIC: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY, 2022–2029 (USD MILLION)          116

TABLE 88           LATIN AMERICA: SURGICAL SPONGES MARKET FOR OTHER SHAPES, BY COUNTRY, 2022–2029 (USD MILLION)          117

TABLE 89           SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)          119

TABLE 90           STERILE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY         120

TABLE 91           STERILE SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION) 120

TABLE 92           NORTH AMERICA: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          121

TABLE 93          EUROPE: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          121

TABLE 94           ASIA PACIFIC: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          122

TABLE 95           LATIN AMERICA: STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          122

TABLE 96           NON-STERILE SURGICAL SPONGES: PRODUCTS OFFERED, BY COMPANY         123

TABLE 97           NON-STERILE SURGICAL SPONGES MARKET, BY REGION,

2022–2029 (USD MILLION)          123

TABLE 98           NORTH AMERICA: NON-STERILE SURGICAL SPONGES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            124

TABLE 99           EUROPE: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          124

TABLE 100         ASIA PACIFIC: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 101         LATIN AMERICA: NON-STERILE SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 102         SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 127

TABLE 103         TOTAL NUMBER OF INGUINAL HERNIA REPAIR PROCEDURES, 2021 VS. 2022     128

TABLE 104         SURGICAL SPONGES MARKET FOR GENERAL SURGERY, BY REGION,

2022–2029 (USD MILLION)          128

TABLE 105         NORTH AMERICA: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            129

TABLE 106         EUROPE: SURGICAL SPONGES MARKET FOR GENERAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)       129

TABLE 107         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 108         LATIN AMERICA: SURGICAL SPONGES MARKET FOR GENERAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            130

TABLE 109         SURGICAL SPONGES MARKET FOR NEUROSURGERY, BY REGION,

2022–2029 (USD MILLION)          131

TABLE 110         NORTH AMERICA: SURGICAL SPONGES MARKET FOR NEUROSURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            131

TABLE 111         EUROPE: SURGICAL SPONGES MARKET FOR NEUROSURGERY, BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 112         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR NEUROSURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 113         LATIN AMERICA: SURGICAL SPONGES MARKET FOR NEUROSURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            133

TABLE 114         SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY REGION,

2022–2029 (USD MILLION)          134

TABLE 115         NORTH AMERICA: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION)            134

TABLE 116         EUROPE: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY,

2022–2029 (USD MILLION)          135

TABLE 117         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION)            135

TABLE 118         LATIN AMERICA: SURGICAL SPONGES MARKET FOR LAPAROTOMY, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 119         SURGICAL SPONGES MARKET FOR DENTAL SURGERY, BY REGION,

2022–2029 (USD MILLION)          137

TABLE 120         NORTH AMERICA: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            137

TABLE 121         EUROPE: SURGICAL SPONGES MARKET FOR DENTAL SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)       138

TABLE 122         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            138

TABLE 123         LATIN AMERICA: SURGICAL SPONGES MARKET FOR DENTAL SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            139

TABLE 124         SURGICAL SPONGES MARKET FOR ENT SURGERY, BY REGION,

2022–2029 (USD MILLION)          140

TABLE 125         NORTH AMERICA: SURGICAL SPONGES MARKET FOR ENT SURGERY,

BY COUNTRY, 2022–2029 (USD MILLION)            140

TABLE 126         EUROPE: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY,

2022–2029 (USD MILLION)          141

TABLE 127         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)       141

TABLE 128         LATIN AMERICA: SURGICAL SPONGES MARKET FOR ENT SURGERY, BY COUNTRY, 2022–2029 (USD MILLION)       142

TABLE 129         SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS, BY REGION,

2022–2029 (USD MILLION)          143

TABLE 130         NORTH AMERICA: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)            143

TABLE 131         EUROPE: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)            144

TABLE 132         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)            144

TABLE 133         LATIN AMERICA: SURGICAL SPONGES MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)            145

TABLE 134         SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION)          147

TABLE 135         SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY REGION, 2022–2029 (USD MILLION)              148

TABLE 136         NORTH AMERICA: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 149

TABLE 137         EUROPE: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              149

TABLE 138         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)              150

TABLE 139         LATIN AMERICA: SURGICAL SPONGES MARKET FOR HOSPITALS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2029 (USD MILLION) 150

TABLE 140         SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS, BY REGION,

2022–2029 (USD MILLION)          151

TABLE 141         NORTH AMERICA: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)          151

TABLE 142         EUROPE: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 143         ASIA PACIFIC: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 144         LATIN AMERICA: SURGICAL SPONGES MARKET FOR SPECIALTY CLINICS,

BY COUNTRY, 2022–2029 (USD MILLION)            153

TABLE 145         SURGICAL SPONGES MARKET, BY REGION, 2022–2029 (USD MILLION)          155

TABLE 146         NORTH AMERICA: MACROECONOMIC OUTLOOK          156

TABLE 147         NORTH AMERICA: SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          158

TABLE 148         NORTH AMERICA: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          158

TABLE 149         NORTH AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          158

TABLE 150         NORTH AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          159

TABLE 151         NORTH AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          159

TABLE 152         NORTH AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          159

TABLE 153        NORTH AMERICA: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          160

TABLE 154         US: NUMBER OF SURGERIES PERFORMED, 2022–2029 (USD MILLION)          161

TABLE 155         US: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          161

TABLE 156         US: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 161

TABLE 157         US: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION)          162

TABLE 158         US: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 162

TABLE 159         US: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162

TABLE 160         US: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 163

TABLE 161         CANADA: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              164

TABLE 162         CANADA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 164

TABLE 163         CANADA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     164

TABLE 164         CANADA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 165

TABLE 165         CANADA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)     165

TABLE 166         CANADA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          165

TABLE 167         CANADA: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          166

TABLE 168         EUROPEAN UNION: MACROECONOMIC OUTLOOK       167

TABLE 169         EUROPE: SURGICAL SPONGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 170         EUROPE: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 168

TABLE 171         EUROPE: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     168

TABLE 172         EUROPE: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 168

TABLE 173         EUROPE: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)     169

TABLE 174         EUROPE: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          169

TABLE 175         EUROPE: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          169

TABLE 176         GERMANY: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022      170

TABLE 177         GERMANY: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 171

TABLE 178         GERMANY: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          171

TABLE 179         GERMANY: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 171

TABLE 180         GERMANY: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          172

TABLE 181         GERMANY: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          172

TABLE 182         GERMANY: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          172

TABLE 183         UK: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              173

TABLE 184         UK: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          174

TABLE 185         UK: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 174

TABLE 186         UK: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION)          174

TABLE 187         UK: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 175

TABLE 188         UK: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 175

TABLE 189         UK: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 175

TABLE 190         FRANCE: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              176

TABLE 191         FRANCE: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 177

TABLE 192         FRANCE: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     177

TABLE 193         FRANCE: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 177

TABLE 194         FRANCE: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)     178

TABLE 195         FRANCE: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          178

TABLE 196         FRANCE: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          178

TABLE 197         ITALY: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              179

TABLE 198         ITALY: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          180

TABLE 199         ITALY: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 180

TABLE 200         ITALY: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 180

TABLE 201         ITALY: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 181

TABLE 202         ITALY: SURGICAL SPONGES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     181

TABLE 203         ITALY: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 181

TABLE 204         SPAIN: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              182

TABLE 205         SPAIN: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          183

TABLE 206         SPAIN: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 183

TABLE 207         SPAIN: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 183

TABLE 208         SPAIN: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 184

TABLE 209         SPAIN: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          184

TABLE 210         SPAIN: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 184

TABLE 211         REST OF EUROPE: SURGICAL OPERATIONS AND PROCEDURES PERFORMED IN HOSPITALS, 2021 (PER 100,000 INHABITANTS)  186

TABLE 212         REST OF EUROPE: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          186

TABLE 213         REST OF EUROPE: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)        187

TABLE 214         REST OF EUROPE: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          187

TABLE 215        REST OF EUROPE: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          187

TABLE 216         REST OF EUROPE: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          188

TABLE 217        REST OF EUROPE: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          188

TABLE 218         EAST ASIA & PACIFIC: MACROECONOMIC OUTLOOK    189

TABLE 219         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          191

TABLE 220         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)     191

TABLE 221         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          192

TABLE 222         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          192

TABLE 223         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          192

TABLE 224        ASIA PACIFIC: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          193

TABLE 225         ASIA PACIFIC: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          193

TABLE 226         CHINA: CANCER INCIDENCE, MORTALITY, AND PREVALENCE, BY TYPE, 2022   194

TABLE 227         CHINA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195

TABLE 228         CHINA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     195

TABLE 229         CHINA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 195

TABLE 230         CHINA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 196

TABLE 231         CHINA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          196

TABLE 232         CHINA: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 196

TABLE 233         JAPAN: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          198

TABLE 234         JAPAN: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 198

TABLE 235         JAPAN: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 198

TABLE 236         JAPAN: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 199

TABLE 237         JAPAN: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          199

TABLE 238         JAPAN: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 199

TABLE 239         INDIA: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION)          201

TABLE 240         INDIA: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION) 201

TABLE 241         INDIA: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 201

TABLE 242         INDIA: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION) 202

TABLE 243         INDIA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)        202

TABLE 244         INDIA: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION) 202

TABLE 245         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          203

TABLE 246         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          204

TABLE 247         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          204

TABLE 248         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          204

TABLE 249         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          205

TABLE 250         REST OF ASIA PACIFIC: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          205

TABLE 251         LATIN AMERICA & CARIBBEAN: MACROECONOMIC OUTLOOK              206

TABLE 252         LATIN AMERICA: SURGICAL SPONGES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          206

TABLE 253         LATIN AMERICA: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          207

TABLE 254         LATIN AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          207

TABLE 255         LATIN AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          208

TABLE 256         LATIN AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          208

TABLE 257         LATIN AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          208

TABLE 258         LATIN AMERICA: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          209

TABLE 259         BRAZIL: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 210

TABLE 260         BRAZIL: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     210

TABLE 261         BRAZIL: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 210

TABLE 262         BRAZIL: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)     211

TABLE 263         BRAZIL: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          211

TABLE 264         BRAZIL: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION)     211

TABLE 265         MEXICO: SURGICAL PROCEDURES PERFORMED, 2021 VS. 2022              212

TABLE 266         MEXICO: SURGICAL SPONGES MARKET, BY TYPE, 2022–2029 (USD MILLION) 213

TABLE 267         MEXICO: SURGICAL SPONGES MARKET, BY MATERIAL, 2022–2029 (USD MILLION)     213

TABLE 268         MEXICO: SURGICAL SPONGES MARKET, BY SHAPE, 2022–2029 (USD MILLION) 213

TABLE 269         MEXICO: SURGICAL SPONGES MARKET, BY STERILITY, 2022–2029 (USD MILLION)     214

TABLE 270         MEXICO: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          214

TABLE 271         MEXICO: SURGICAL SPONGES MARKET, BY END USER, 2022–2029 (USD MILLION)     214

TABLE 272         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          216

TABLE 273         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          216

TABLE 274         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          217

TABLE 275         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          217

TABLE 276         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          218

TABLE 277         REST OF LATIN AMERICA: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)        218

TABLE 278         MIDDLE EAST & NORTH AFRICA: MACROECONOMIC OUTLOOK         219

TABLE 279         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          220

TABLE 280         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)        220

TABLE 281         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          221

TABLE 282         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          221

TABLE 283         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          222

TABLE 284         MIDDLE EAST & AFRICA: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          222

TABLE 285         GCC COUNTRIES: MACROECONOMIC OUTLOOK           223

TABLE 286         GCC COUNTRIES: SURGICAL SPONGES MARKET, BY TYPE,

2022–2029 (USD MILLION)          224

TABLE 287        GCC COUNTRIES: SURGICAL SPONGES MARKET, BY MATERIAL,

2022–2029 (USD MILLION)          224

TABLE 288         GCC COUNTRIES: SURGICAL SPONGES MARKET, BY SHAPE,

2022–2029 (USD MILLION)          225

TABLE 289        GCC COUNTRIES: SURGICAL SPONGES MARKET, BY STERILITY,

2022–2029 (USD MILLION)          225

TABLE 290         GCC COUNTRIES: SURGICAL SPONGES MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          225

TABLE 291         GCC COUNTRIES: SURGICAL SPONGES MARKET, BY END USER,

2022–2029 (USD MILLION)          226

TABLE 292         OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS           227

TABLE 293         SURGICAL SPONGES MARKET: DEGREE OF COMPETITION              230

TABLE 294         SURGICAL SPONGES MARKET: TYPE FOOTPRINT          234

TABLE 295         SURGICAL SPONGES MARKET: MATERIAL FOOTPRINT 234

TABLE 296         SURGICAL SPONGES MARKET: SHAPE FOOTPRINT        235

TABLE 297         SURGICAL SPONGES MARKET: STERILITY FOOTPRINT 235

TABLE 298         SURGICAL SPONGES MARKET: APPLICATION FOOTPRINT              236

TABLE 299         SURGICAL SPONGES MARKET: END-USER FOOTPRINT 236

TABLE 300         SURGICAL SPONGES MARKET: REGION FOOTPRINT     237

TABLE 301         SURGICAL SPONGES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            239

TABLE 302         SURGICAL SPONGES MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS        239

TABLE 303         SURGICAL SPONGES MARKET: DEALS, JANUARY 2021–JUNE 2024      242

TABLE 304         SURGICAL SPONGES MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024          242

TABLE 305         SURGICAL SPONGES MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JUNE 2024           242

TABLE 306         JOHNSON & JOHNSON SERVICES, INC.: BUSINESS OVERVIEW              243

TABLE 307         JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED              244

TABLE 308         MCKESSON CORPORATION: BUSINESS OVERVIEW         246

TABLE 309         MCKESSON CORPORATION: PRODUCTS OFFERED        247

TABLE 310         CARDINAL HEALTH: BUSINESS OVERVIEW        249

TABLE 311         CARDINAL HEALTH: PRODUCTS OFFERED        250

TABLE 312         3M: COMPANY OVERVIEW         252

TABLE 313         3M: PRODUCTS OFFERED          253

TABLE 314         3M: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024 254

TABLE 315         INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW        255

TABLE 316         INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED          256

TABLE 317         INTEGRA LIFESCIENCES CORPORATION: DEALS, JANUARY 2021–JUNE 2024 257

TABLE 318         MEDICOM: COMPANY OVERVIEW          258

TABLE 319         MEDICOM: PRODUCTS OFFERED          258

TABLE 320         MEDLINE INDUSTRIES, LP.: BUSINESS OVERVIEW          260

TABLE 321         MEDLINE INDUSTRIES, LP.: PRODUCT OFFERED            260

TABLE 322         MEDLINE INDUSTRIES, LP.: EXPANSIONS, JANUARY 2021–JUNE 2024      261

TABLE 323         DEROYAL INDUSTRIES, INC.: BUSINESS OVERVIEW        262

TABLE 324         DEROYAL INDUSTRIES, INC.: PRODUCT OFFERED         262

TABLE 325         DUKAL LLC: BUSINESS OVERVIEW         263

TABLE 326         DUKAL LLC: PRODUCT OFFERED          263

TABLE 327         DYNAREX CORPORATION: BUSINESS OVERVIEW           265

TABLE 328         DYNAREX CORPORATION: PRODUCT OFFERED             265

LIST OF FIGURES

FIGURE 1           SURGICAL SPONGES MARKET: RESEARCH DESIGN        30

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND

DEMAND-SIDE PARTICIPANTS 35

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION    35

FIGURE 4           SURGICAL SPONGES MARKET: REVENUE SHARE ANALYSIS              36

FIGURE 5           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   38

FIGURE 6           SURGICAL SPONGES MARKET: TOP-DOWN APPROACH 39

FIGURE 7           DATA TRIANGULATION METHODOLOGY         40

FIGURE 8           SURGICAL SPONGES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)          43

FIGURE 9           SURGICAL SPONGES MARKET, BY MATERIAL, 2024 VS. 2029 (USD MILLION) 44

FIGURE 10         SURGICAL SPONGES MARKET, BY SHAPE, 2024 VS. 2029 (USD MILLION)          44

FIGURE 11         SURGICAL SPONGES MARKET, BY STERILITY, 2024 VS. 2029 (USD MILLION) 45

FIGURE 12         SURGICAL SPONGES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 46

FIGURE 13         SURGICAL SPONGES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 46

FIGURE 14         GEOGRAPHICAL SNAPSHOT OF SURGICAL SPONGES MARKET              47

FIGURE 15         RISING VOLUME OF SURGERIES AND INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH      48

FIGURE 16         COTTON GAUZE SPONGES ACCOUNTED FOR LARGEST SHARE IN 2023 49

FIGURE 17         CHINA TO REGISTER HIGHEST GROWTH IN SURGICAL SPONGES MARKET FROM 2024 TO 2029 50

FIGURE 18         APAC TO WITNESS HIGHEST GROWTH OVER FORECAST PERIOD              51

FIGURE 19         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING

FORECAST PERIOD       51

FIGURE 20         SURGICAL SPONGES MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND TRENDS             52

FIGURE 21         VALUE CHAIN ANALYSIS OF SURGICAL SPONGES MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES              61

FIGURE 22         SURGICAL SPONGES MARKET: SUPPLY CHAIN ANALYSIS              62

FIGURE 23         SURGICAL SPONGES MARKET: ECOSYSTEM      63

FIGURE 24         SURGICAL SPONGES MARKET: KEY STAKEHOLDERS IN ECOSYSTEM     64

FIGURE 25         SURGICAL SPONGES MARKET: PORTER’S FIVE FORCES ANALYSIS          65

FIGURE 26         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67

FIGURE 27         KEY BUYING CRITERIA FOR SURGICAL SPONGE END USERS              67

FIGURE 28         PATENT ANALYSIS FOR SURGICAL SPONGES (JANUARY 2013–DECEMBER 2023)           75

FIGURE 29         REVENUE SHIFT IN SURGICAL SPONGES MARKET          77

FIGURE 30         NORTH AMERICA: SURGICAL SPONGES MARKET SNAPSHOT              157

FIGURE 31         ASIA PACIFIC: SURGICAL SPONGES MARKET SNAPSHOT              190

FIGURE 32         REVENUE ANALYSIS OF TOP PLAYERS IN SURGICAL SPONGES MARKET            229

FIGURE 33         MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL SPONGES

MARKET (2023) 229

FIGURE 34         SURGICAL SPONGES MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2023  232

FIGURE 35         SURGICAL SPONGES MARKET: COMPANY FOOTPRINT 233

FIGURE 36         SURGICAL SPONGES MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023             238

FIGURE 37         EV/EBITDA OF KEY VENDORS   240

FIGURE 38         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 240

FIGURE 39         SURGICAL SPONGES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS          241

FIGURE 40         JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2023)   244

FIGURE 41         MCKESSON CORPORATION: COMPANY SNAPSHOT (2024)              246

FIGURE 42         CARDINAL HEALTH: COMPANY SNAPSHOT (2023)         250

FIGURE 43         3M: COMPANY SNAPSHOT (2023)           253

FIGURE 44         INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023)          256